| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/ADC.67.3.285 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1793643 |
| https://europepmc.org/articles/PMC1793643?pdf=render | ||
| P932 | PMC publication ID | 1793643 |
| P698 | PubMed publication ID | 1575550 |
| P5875 | ResearchGate publication ID | 21579280 |
| P2093 | author name string | A. D. Milner | |
| M. L. Everard | |||
| N. R. Ruggins | |||
| V. Noble | |||
| P2860 | cites work | Effect of salbutamol in infants with wheezy bronchitis | Q34985560 |
| At what age do bronchodilator drugs work? | Q34986404 | ||
| Bronchodilator effect of inhaled ipratropium bromide in wheezy toddlers | Q35115218 | ||
| Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life | Q35117690 | ||
| Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol | Q35151525 | ||
| Oral corticosteroids for wheezing attacks under 18 months | Q35602392 | ||
| Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis | Q35605145 | ||
| Impact of vitamin A supplementation on childhood mortality. A randomised controlled community trial | Q36414513 | ||
| Bronchodilators for wheezy infants? | Q38944851 | ||
| Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors | Q41127081 | ||
| Particle size of beclomethasone dipropionate produced by two nebulisers and two spacing devices | Q41137531 | ||
| New method of beclomethasone aerosol administration to children under 4 years of age | Q41833409 | ||
| Controlled trial of budesonide given by the nebuhaler in preschool children with asthma | Q41874250 | ||
| Spacer device with face mask attachment for giving bronchodilators to infants with asthma | Q42145937 | ||
| Ipratropium bromide and airways function in wheezy infants | Q42995470 | ||
| Effect of massive dose vitamin A on morbidity and mortality in Indian children | Q43628437 | ||
| Reduced mortality among children in southern India receiving a small weekly dose of vitamin A. | Q43922010 | ||
| Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants | Q44885980 | ||
| Inhaled budesonide for treatment of recurrent wheezing in early childhood | Q48920350 | ||
| Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children | Q49156983 | ||
| Efficacy of vitamin A in reducing preschool child mortality in Nepal | Q57134706 | ||
| PEP-spacer: an adaptation for administration of MDI to infants | Q57638491 | ||
| Aerosolized budesonide in asthmatic infants: a double blind study | Q68660918 | ||
| Pediatrics | Q70170365 | ||
| Artificial urinary sphincters | Q70279629 | ||
| Theophylline therapy in bronchiolitis. A retrospective study | Q70964085 | ||
| Long-term follow-up of infants and children treated with beclomethasone aerosol by a special inhalation device | Q71514258 | ||
| Dexamethasone and salbutamol in the treatment of acute wheezing in infants | Q72542487 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | wheeze | Q517104 |
| P304 | page(s) | 285-288 | |
| P577 | publication date | 1992-03-01 | |
| P1433 | published in | Archives of Disease in Childhood | Q4787296 |
| P1476 | title | Inhaled budesonide for chronic wheezing under 18 months of age | |
| P478 | volume | 67 |
| Q34797065 | A non-electrostatic spacer for aerosol delivery |
| Q32049879 | A review of budesonide inhalation suspension in the treatment of pediatric asthma |
| Q37754988 | Aerosol therapy in infants and toddlers: past, present and future |
| Q93501243 | Asthma and other wheezing disorders in children |
| Q51053496 | Asthma, growth and inhaled corticosteroids. |
| Q44060729 | Beclomethasone dipropionate and salbutamol by metered dose inhaler in infants and small children with recurrent wheezing |
| Q34424877 | Budesonide for chronic asthma in children and adults |
| Q41753582 | Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma |
| Q44821611 | Conflicting therapeutic aspects during acute bronchiolitis in infants |
| Q59737295 | Consenso sobre tratamiento del asma en pediatría |
| Q41234688 | Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation? |
| Q41680896 | Delivery of inhaled medication to children |
| Q71049995 | Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction |
| Q74591046 | Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing |
| Q34796740 | Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children |
| Q41728966 | Efficacy and safety of inhaled corticosteroids. New developments |
| Q45143046 | Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants |
| Q51701536 | Efficacy of steroid treatments in the asthmatic preschool child. |
| Q30575446 | Feasibility of aerosol drug delivery to sleeping infants: a prospective observational study |
| Q54718751 | Inhalation treatment: errors in application and difficulties in acceptance of the devices are frequent in wheezy infants and young children. |
| Q40832408 | Inhaled corticosteroids in children. Is there a 'safe' dosage? |
| Q47712458 | Inhaled corticosteroids in wheezy infants |
| Q41054747 | Inhalers and nebulizers: which to choose and why. |
| Q35276464 | Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears! |
| Q43688383 | Nebulized budesonide after hospitalization for recurrent bronchial obstruction in children younger than 18 months |
| Q71309351 | Nebulized flunisolide in infants and young children with asthma: a pilot study |
| Q41693586 | Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children |
| Q33860044 | Once-daily inhaled corticosteroids in children with asthma: nebulisation |
| Q28344646 | Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone |
| Q44157369 | Prevention of short and long term recurrences after a first episode of bronchiolitis |
| Q35262745 | Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing |
| Q40485832 | Respiratory syncytial virus |
| Q33732334 | Respiratory syncytial virus infection |
| Q34797233 | The effects of inhaled beclomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infants |
| Q35169765 | The influence of inhaler selection on efficacy of asthma therapies |
| Q41151318 | The role of corticosteroids in respiratory diseases of children |
| Q71492962 | Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and prednisolone |
| Q33623852 | Use of budesonide in severe asthmatics aged 1-3 years |
| Q73571879 | [Bronchiolitis in infants. Corticoids] |
| Q80032598 | [SENP-SEICAP (Spanish Society of Pediatric Pneunomology. Spanish Society of Pediatric Clinical Immunology and Allergology) consensus on asthma, pneumonology, and pediatric allergy (Draft)] |
Search more.